State Street Corp Hoth Therapeutics, Inc. Transaction History

State Street Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	BUY	$0.52 - $1.3 $715 - $1,788	1,376 Added 5.08%	28,476 $20,000
Q2 2021 Aug 16, 2021	BUY	$1.31 - $2.14 $35,501 - $57,994	27,100 New	27,100 $43,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.